EAU 2014 - Poster: Consistent long-term efficacy and safety of onabotulinumtoxinA in patients with neurogenic detrusor overactivity: Final results of repeated treatments up to 4 years

STOCKHOLM, SWEDEN (UroToday.com) - Presented by Gilles Karsenty,1 Heinrich Schulte-Baukloh,2 Roger Dmochowski,3 Karen Ethans,4 Brenda Jenkins,5 Steven Guard,6 Ho-Jin Lee,7 Michael Kennelly8 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

Poster-693 EAU thumb

1Aix-Marseille Université, Marseille, France; 2St. Hedwig-Krankenhaus, Berlin, Germany; 3Vanderbilt University Medical Center, Nashville, TN, USA; 4University of Manitoba, Winnipeg, Canada; 5Allergan, Inc., Irvine, CA, USA; 6Allergan, Ltd., Marlow, UK; 7Allergan, Inc., Bridgewater, NJ, USA; 8Carolinas Medical Center, Charlotte, NC, USA

 

Conference Coverage
 
Recent data from conferences worldwide
  • 2020 Annual Virtual Meeting / Oct 17
  • 2020 Annual Congress / October 10 - 11
  • 2020 Annual Meeting / October 1-3
  • 2020 Virtual Congress / September 19-21
  • 2020 BCAN Think Tank Virtual / August 7
  • 2020 Virtual Education Program / August 8-10
  • 2020 Annual Meeting / July 17-19 / EAU Virtual Program
  • SUO - AUA 2020 Summer Webcast / July 18
  • 2020 Annual Meeting / June 27-28 / AUA Live Virtual Program
  • 2020 Annual Meeting / May 29-31 / Virtual Scientific Program
  • 2020 Annual Meeting / February 13-15 / San Francisco, CA
  • 2019 Annual Meeting / December 4-6 / Washington, DC
  • 2019 Biennial Meeting / August 29-31 / Basel, Switzerland